The ether-à-go-go (Eag) superfamily of K v channels comprises the three conserved families of Eag (K v 10), ether-à-go-go-related gene (Erg; K v 11), and ether-à-go-go-gene-like (Elk; K v 12) channels. These channels give rise to voltage-dependent K + currents in many cell types (Bauer & Schwarz, 2001; Bauer & Schwarz, 2018) . The best characterised member, K v 11.1 (termed hERG for the human isoform), engenders rapidly activating K + current I Kr responsible for membrane repolarisation in cardiac myocytes (Sanguinetti, Jiang, Curran, & Keating, 1995) . As I Kr determines duration and end of heart action potentials, loss of K v 11.1 function constitutes a frequent cause of cardiac dysfunction in humans Keating & Sanguinetti, 2001; Mitcheson, Chen, Lin, Culberson, & Sanguinetti, 2000; Sanguinetti et al., 1995; Trudeau, Warmke, Ganetzky, & Robertson, 1995) . Mutations in KCNH2, the gene encoding K v 11.1, cause congenital long QT (LQT) syndrome-2 characterised by a prolonged QT interval and polymorphic ventricular arrhythmias (torsade de pointes)
that may lead to recurrent syncope or sudden death Sanguinetti et al., 1995) . More common, however, are acquired forms of LQT syndrome through drug-induced inhibition of K v 11.1 (Keating & Sanguinetti, 2001; Roden, 1996; Sanguinetti et al., 1995) .
K v 11.1 channels are extremely sensitive to a wide variety of drugs including substituted quinolines (quinidine, quinine, and chloroquine),
antiarrhythmic agents (e.g., MK-499 and dofetilide), and many other substances (e.g., terfenadine, cisapride, and vesnarinone ; Furutani et al., 2011; Kamiya, Mitcheson, Yasui, Kodama, & Sanguinetti, 2001; Lees-Miller, Duan, Teng, & Duff, 2000; Mitcheson et al., 2000; Mitcheson et al., 2005; Sanchez-Chapula, Ferrer, Navarro-Polanco, & Sanguinetti, 2003 ; Sanchez-Chapula, Navarro-Polanco, Culberson, . All of these substances may cause undesired prolongation of cardiac action potentials by inhibiting K v 11.1 (Sanguinetti et al., 1995) . The high susceptibility of human K v 11.1 to these structurally divergent drugs is governed by amino acids facing the channel's central cavity to form hydrophobic-binding pockets (Wang & MacKinnon, 2017) . Mutagenesis studies have shown that amino acids in the inner pore helix (threonine 623), selectivity filter (serine 624 and valine 625), and tyrosine 652/phenylalanine 656 of the sixth transmembrane segment (S6) determine the susceptibility of drug-induced inhibition in K v 11.1 (Mitcheson et al., 2000; SanchezChapula et al., 2002; Sanchez-Chapula et al., 2003; Wang & MacKinnon, 2017) . Some of these residues are involved in drug binding (threonine 623, serine 624, tyrosine 652, and phenylalanine 656 ; Wang & MacKinnon, 2017) , whereas others (e.g., valine 625 and also asparagine 588, serine 631, and serine 620) have been shown to control drug sensitivity through contributing to channel inactivation that is necessary for K v 11.1 inhibition through many high-affinity blockers (Ficker, Jarolimek, & Brown, 2001; Ficker, Jarolimek, Kiehn, Baumann, & Brown, 1998; Kamiya, Niwa, Mitcheson, & Sanguinetti, 2006; Perrin, Kuchel, Campbell, & Vandenberg, 2008; Wu, Gardner, & Sanguinetti, 2015) . Further, phenylalanine 557 located in the S5 helix is involved in binding of some drugs (Helliwell et al., 2018; Saxena et al., 2016) .
Most of these residues are conserved in K v 10 channels, and accordingly, the K v 10.1 isoform exhibits similarly high sensitivity to some substances (Schonherr, Gessner, Lober, & Heinemann, 2002) .
However, K v 10.2 is significantly less susceptible to drug-induced inhibition, indicating that additional motifs might contribute to drug binding in certain members of the superfamily (Chen, Seebohm, & Sanguinetti, 2002; Gessner, Zacharias, Bechstedt, Schonherr, & Heinemann, 2004; Schonherr et al., 2002) . In fact, it has been shown that high-affinity blockers of K v 11.1 are less effective on K v 10 channels, as these isoforms do not inactivate. This suggests that conformational reorientation of relevant residues associated with inactivation that are necessary for inhibition of K V 11.1 is absent in K v 10 channels Ficker et al., 1998; Ficker et al., 2001 ).
In contrast to K v 10 and K v 11, only little information is available on the three members of the K v 12 (Elk) family predominantly expressed in neurons (Engeland, Neu, Ludwig, Roeper, & Pongs, 1998; Miyake, Mochizuki, Yokoi, Kohda, & Furuichi, 1999; Saganich, Machado, & Rudy, 2001; Shi et al., 1998; Trudeau, Titus, Branchaw, Ganetzky, & Robertson, 1999; Zou et al., 2003) . K v 12.2 regulates excitability of hippocampal neurons (Zhang et al., 2010) , but no physiological role has been assigned to K v 12.1 and K v 12.3 channels yet. Recent studies provided significant insight into functional characteristics of K v 12.1 (Dai & Zagotta, 2017; Dierich, Evers, Wilke, & Leitner, 2018; Kazmierczak et al., 2013; Li et al., 2015) , but it is unknown whether K v 12 channels are equipped with a high affinity drug-binding pocket as K v 10.1 and K v 11.1.
We analysed the sensitivity of human K v 12.1 to quinine, a substituted quinoline that blocks K v 11.1 channels at low micromolar concentrations (Gessner et al., 2004; Mitcheson et al., 2000; Sanchez-Chapula et al., 2003; Schonherr et al., 2002) . Quinine also inhibited recombinant K v 12.1 channels, but their sensitivity was 10-fold lower than that of K v 11.1. Contrary to K v 11.1, quinine-dependent block of K v 12.1 was largely voltage-independent and the substance
What is already known
• Drug-induced inhibition of K v 11.1 (hERG) is a frequent cause of sudden death in humans.
• It is not known whether closely related K v 12 channels are also sensitive to drug-dependent inhibition.
What this study adds
• Low quinine sensitivity, affinity, and characteristics of inhibition of K v 12.1 channels are determined by H462.
• Drug sensitivity of K v 11.1 and K v 12.1 is different but determined by homologous amino acid positions.
What is the clinical significance
• Drug-binding pockets are not conserved in Eag superfamily members, but channel architecture is similar.
• Our findings facilitate the understanding of the arrhythmogenic actions of quinine.
induced channel opening at more depolarised membrane potentials.
Mutagenesis of histidine at position 462 (H462) into the homologous 
| Electrophysiological recordings
Whole-cell patch clamp recordings were performed at room temperature (22-25°C) with an HEKA EPC10 USB patch clamp amplifier controlled by PatchMaster software (HEKA, Lambrecht, Germany;
Patchmaster, RRID:SCR_000034). Voltage clamp recordings were low-pass filtered at 2 kHz and sampled at 5 kHz. The series resistance (R s ) was kept below 6 MΩ, and R s was compensated throughout the recordings (80-90%; Leitner, Halaszovich, & Oliver, 2011 Figure 3e ). For presentation, whole-cell currents were normalised to cell capacitance (current density; pA·pF −1 ) or to baseline current amplitudes (I/I 0 ; normalised current).
| Data and statistical analysis
The data and statistical analysis comply with the recommendations of the British Journal of Pharmacology on experimental design and analysis in pharmacology (Curtis et al., 2018 and there was no significant variance inhomogeneity. Significance was assigned at P ≤ 0.05 (*P ≤ 0.05). Data subjected to statistical analysis have n over 5 per group, and data are presented as mean ± standard error of the means (SEM). In electrophysiological experiments, n represents the number of individual cells and accordingly the number of independent experiments (no pseudo-replication).
| Molecular modelling
A K v 12.1 homology model of the pore module (residues S352-Y477) in the open/inactive conformation was built using the programme modeller 9v.17 (Webb & Sali, 2016 , RRID:SCR_008395) based on the cryo-EM structure of the hERG (human K v 11.1) channel (pdb identifier: 5VA1, 3.7 Å resolution; Wang & MacKinnon, 2017 ions (Best et al., 2012; Klauda et al., 2010; MacKerell et al., 1998) .
Electrostatics were modelled using particle mesh Ewald (Darden, York, & Pedersen, 1993) , and LINCS was used to constrain covalent chemical bonds to hydrogens (Hess, Bekker, Berendsen, & Fraaije, 1997) .
Temperature was maintained at 310 K using velocity rescaling (Vrescale; Bussi, Donadio, & Parrinello, 2007) , and semi-isotropic pressure coupling was accomplished using the Parrinello-Rahman barostat (Parrinello & Rahman, 1981) . MD trajectories were analysed using VMD v.1.9.2 (VMD, RRID:SCR_001820; Humphrey, Dalke, & Schulten, 1996) and GROMACS.
| Materials
Quinine was purchased from Tocris Bioscience (Bristol, UK) and was diluted in extracellular solution to concentrations indicated in Section 3. Quinine was applied locally via a glass capillary through a custom-made application system.
| Nomenclature of targets and ligands
Key protein targets and ligands in this article are hyperlinked to corresponding entries in http://www.guidetopharmacology.org, the common portal for data from the IUPHAR/BPS Guide to PHARMA-COLOGY (Harding et al., 2018) , and are permanently archived in the Concise Guide to PHARMACOLOGY 2017/18 (Alexander et al., 2017) . (Dai & Zagotta, 2017; Li et al., 2015) .
Application of quinine (1 mM) shifted the voltage dependence of K v 12.1 to depolarised voltages for both conditioning potentials. As this shift was more pronounced after the depolarised conditioning potential (0 mV; Figure 1d ,e), the degree of mode shift was significantly attenuated to about −23 mV in the presence of the substance (Figure 1e ). Application of quinine (1 mM) inhibited both steady-state currents and tail currents through K v 12.1 channels (Figure 1g ,h).
Following both conditioning potentials, quinine-induced inhibition of steady-state K v 12.1 currents was the same for all activating voltages (Figure 1i ; n = 6; e.g., for conditioning potential −60 mV: not significant 1 was voltageindependent (presented as % inhibition from data shown in (g); ns, no significant difference for quinine block between activating voltages of −40 and 20 mV). Note that quinine block was significantly more pronounced, when K v 12.1 channels were activated at membrane potentials more positive than −30 mV. *Significant difference of quinine block for both conditioning potentials (ns) between −40 mV and +20 mV, P = 0.54), that is, quinine inhibited K v 12.1 channels in a voltage-independent manner. However, quininedependent block was significantly more pronounced following the hyperpolarised conditioning potential (−60 mV) for activating voltages more positive than −30 mV (indicated by "*" in Figure 1i ). These data demonstrated that to some extent, K v 12.1 channels were more sensitive to quinine block after conditioning depolarisation of the membrane, and that accordingly, quinine block of K v 12.1 channels depended on mode shift.
3.2 | Quinine is a voltage-and mode shift-dependent inhibitor of K v 11.1 channels
We then compared our findings on K v 12.1 to quinine-dependent inhibition of closely related K v 11.1. In line with a previous study Thus, for K v 11.1 channels, quinine-induced inhibition depended on mode shift (c.f. quinidine; Furutani et al., 2011) , but (in contrast to K v 12.1) the K v 11.1 channels apparently were more sensitive to quinine following the depolarised conditioning potential, when activated at negative membrane potentials.
| Functional characterisation of K v 12.1(H462Y) channels
Sensitivity of human K v 11.1 channels to several drugs has been attributed to the amino acids T623, V625, Y652, and F656, located in the channels inner pore helix, selectivity filter, or sixth transmembrane segment (S6; Figure 3a ; Lees-Miller et al., 2000; Mitcheson et al., 2000; Sanchez-Chapula et al., 2002; Sanchez-Chapula et al., 2003) . As was more similar to K v 11.1 than to the wild-type channels (Figure 5a ).
Application of quinine induced opening of wild-type K v 12.1 channels at more positive potentials but at more negative values for K v 12.1(H462Y) and K v 11.1 (Figure 5b ). Quinine inhibited K v 12.1 channels in a voltage-independent manner, but quinine block was 
FIGURE 5
The inhibition induced by quinine of K v 12.1(H462Y) channels shows K v 11.1-like characteristics. This figure summarises our findings on K v 12.1 wild-type channels and H462Y mutant as well as on K v 11.1 wild-type channels (data are reproduced from Figures 1-4) .
(a) The affinity of K v 12.1(H462Y) for quinine was 17-fold higher than that of the wild-type and accordingly very similar to K v 11.1. (b) Quinine induced activation of K v 12.1 channels at more positive potentials following the hyperpolarised (−60 mV) and the depolarised conditioning potential (0 mV). In contrast, K v 12.1(H462Y) and K v 11.1 channels activated at more negative membrane potentials in the presence of quinine following the hyperpolarised conditioning potential. Only slight changes of voltage-dependence of K v 12.1(H462Y) and K v 11.1 channels were detected during application of quinine following the depolarised conditioning potential. (c, d) Quinine-mediated block was voltage-independent for K v 12.1 but voltage-dependent for K v 12.1(H462Y). Note that quinine inhibition of K v 11.1 channels was voltage-dependent only following the hyperpolarised conditioning potential. Summaries of quinine-induced inhibition (% of controls) for (c) the hyperpolarised and for (d) the depolarised conditioning membrane potential. Quinine was applied at 1 mM for K v 12.1 channels and at 50 μM for K v 12.1(H462Y) and K v 11.1. Mode shift was induced through conditioning potentials of −60 and 0 mV for K v 12.1 isoforms and at −60 and +40 mV for K v 11.1 channels 3.6 | H462 determines the low quinine affinity of human K v 12.1 channels
To elucidate the molecular principles of the low quinine affinity of K v 12.1, we performed molecular docking and subsequent MD analyses ( Figure 6 ). Quinine binding to the pore helix/S6 domain (amino acids S353-Y477) of K v 12.1 and K v 12.1(H462Y) channels was studied using homology models based on the cryo-EM structure of human K v 11.1 (Wang & MacKinnon, 2017) . We also utilised the available structural information to study quinine binding to K v 11.1 channels. Molecular docking suggested that quinine binds below residue H462 into the central cavity of human K v 12.1 (Figure 6a and quinoline moiety of quinine in the majority of docking poses that shown in Figure 6d , the binding pose of quinine was highly stable in MD simulations, with an RMSD of about 1 Å. In the K v 11.1 cryo-EM structure (Wang & MacKinnon, 2017) , quinine was also predicted to bind slightly below Y652, in the central cavity, with favourable hydrophobic interactions with Y652 residues of all subunits and with F656 from only one subunit. Also, in line with our experimental findings, the estimated affinity of quinine binding to K v 11.1 wild-type channels amounts to −33.9 kJ·mol −1 in our simulations and thus was similar to K v 12.1(H462Y) and higher than that of wild-type K v 12.1 channels.
Further, π-π interactions with Y652 and F656 residues in K v 11.1 from opposite subunits were predicted by these simulations (Figure 6b 
| DISCUSSION
Substituted quinolines are well-known antimalarial agents (quinine and chloroquine) and antiarrhythmic drugs (quinidine; Bozic, Uzelac, Kezic, & Bajcetic, 2018) . As considerable side effect, these substances inhibit K v 11.1 channels at low micromolar concentrations, which may result in acquired (drug-induced) LQT syndrome, syncope, and sudden death in humans (Mitcheson et al., 2005; Mitcheson et al., 2000; Sanguinetti & Tristani-Firouzi, 2006) . Several mutagenesis studies have attributed the susceptibility of K v 11.1 to drug-dependent block to amino acids in the pore domain of these channels, threonine 623 and valine 625 of inner pore helix and selectivity filter, respectively, as well as tyrosine 652 and phenylalanine 656 in the sixth transmembrane segment (S6; Mitcheson et al., 2000; SanchezChapula et al., 2002; Sanchez-Chapula et al., 2003) . On the one hand, valine 625 (together with other residues such as asparagine 588, serine 631, and serine 620) controls drug sensitivity of K v 11.1 through its contribution to channel inactivation that has been shown to be necessary for channel inhibition by several high-affinity blockers (e.g., Kamiya et al., 2006; Perrin et al., 2008; Wu et al., 2015) . On the other hand, some of these residues form hydrophobic pockets in combination with other amino acids at the inner surface of the small central cavity of K v 11.1 channels (Wang & MacKinnon, 2017) . These pockets are endowed with high electronegative potentials and therefore favour binding of positively charged drugs (Wang & MacKinnon, 2017) . The exclusive sensitivity of K v 11.1 to a wide variety of drugs with diverging structures is explained by the absence of such binding pockets in other K + channels (Wang & MacKinnon, 2017) .
Closely related K v 10 and K v 12 channels share high similarity to K v 11.1, which suggests that these channels also possess analogous drug-binding pockets, similar drug sensitivity, and characteristics of inhibition (Bauer & Schwarz, 2018) . Indeed, the respective amino acids determining the susceptibility of K v 11.1 to quinoline block are conserved in K v 10 channels. However, whereas K v 10.1 displayed the same sensitivity to quinidine-dependent inhibition as K v 11.1, quinidine sensitivity of K v 10.2 channels was 100-fold lower (Gessner et al., 2004; Lees-Miller et al., 2000; Sanchez-Chapula et al., 2003; Schonherr et al., 2002) . The lower susceptibility of the K v 10 isoforms to drug-induced inhibition is explained by their lack of inactivation, that is, conformational reorientations during inactivation necessary for high affinity drug block in K v 11.1 do not occur in K v 10 channels Ficker et al., 1998; Ficker et al., 2001 ).
Thus, the lower sensitivity of K v 10 channels indicates that additional drug interaction sites outside the central binding motif might determine drug block in these channels (Gessner et al., 2004; Schonherr et al., 2002) . We wondered whether K v 12.1 channels possess a Yet, as mentioned above, drug sensitivity of K v 11.1 channels is determined by channel inactivation (e.g., through V625, N588, S631, and S620; Ficker et al., 1998; Ficker et al., 2001; Kamiya et al., 2006; Perrin et al., 2008; Wu et al., 2015) . As shown for K v 10 channels Ficker et al., 1998; Ficker et al., 2001 ), lack of inactivation might contribute to low drug sensitivity of K v 12.1 channels. However, above-mentioned residues (except N588 where K v 12.1 has an E) are conserved in K v 12.1 channels, and the single amino acid exchange H462Y sufficed to significantly lower the quinine affinity of these channels (even slightly below that of K v 11.1 channels; c.f. Figure 5a ). We thus estimate that relevance of these amino acids for drug interactions is low in K v 12.1, but we cannot provide any evidence for this assumption at present. Thus, further work is needed to elucidate whether these residues also determine drug sensitivity in K v 12 family members and whether the channel mutant inactivates at all (e.g., during prolonged depolarisations).
Importantly, our findings once again highlight that Y652 determines quinoline sensitivity in closely related K v 11.1 channels , the low quinine affinity of K v 12.1 wild-type channels might prevent generation of an analogous binding site with higher affinity, which might account for lack of voltage dependence in these channels. Thus, similar molecular mechanisms may apply for K v 11.1 and K v 12.1 during drug-induced inhibition, but we cannot provide any evidence for such processes at present.
| Conclusion and significance
We showed that K v 12.1 is a natural variant of Eag superfamily channels with low quinine sensitivity. Thus, the drug-binding pocket in the central cavity is not completely conserved in the Eag superfamily of K v channels, which highlights functional and pharmacological diversity within this group of evolutionary conserved ion channels.
However, our work also demonstrated that the drug-binding pocket exists in K v 12.1 and that thus the overall architecture of the channels is similar. Further work is needed to elucidate whether K v 12.1 channels are also endowed with lower sensitivity to the many more drugs that block closely related K v 11.1.
